ArticleOncotarget2014

Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification.

Yun Sun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.